Effectiveness of Denosumab in Postmenopausal Osteoporosis Treatment: A 1-yr Follow-up Single-center Study
Objective:Denosumab is a humanized monoclonal antibody that targets the receptor activator of nuclear factor kappa-beta ligand. This study aimed to evaluate the effectiveness of denosumab, a new-generation drug, in treating postmenopausal osteoporosis (OP).Materials and Methods:The study included 15...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayinevi
2021-12-01
|
| Series: | Türk Osteoporoz Dergisi |
| Subjects: | |
| Online Access: |
http://www.turkosteoporozdergisi.org/archives/archive-detail/article-preview/effectiveness-of-denosumab-in-postmenopausal-osteo/50624
|